Patents Assigned to ALLOCYTE PHARMACEUTICALS AG
  • SMALL MOLECULE LFA-1 INHIBITORS
    Publication number: 20190040008
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Application
    Filed: August 2, 2018
    Publication date: February 7, 2019
    Applicant: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner BREITENSTEIN, Marianne HUERZELER, Terence KELLY, Riccardo MANCUSO, Gisbert SCHNEIDER, Gabriele WEITZ-SCHMIDT
  • Small molecule LFA-1 inhibitors
    Patent number: 10077238
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: September 18, 2018
    Assignee: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner Breitenstein, Marianne Huerzeler, Terence Kelly, Riccardo Mancuso, Gisbert Schneider, Gabriele Weitz-Schmidt
  • SMALL MOLECULE LFA-1 INHIBITORS
    Publication number: 20170121284
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Application
    Filed: June 10, 2015
    Publication date: May 4, 2017
    Applicant: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner BREITENSTEIN, Marianne HUERZELER, Terence KELLY, Riccardo MANCUSO, Gisbert SCHNEIDER, Gabriele WEITZ-SCHMIDT